BridgeBio Oncology Therapeutics (BBOT) Interest Coverage Ratio (2024 - 2026)

BridgeBio Oncology Therapeutics (BBOT) posted Interest Coverage Ratio of 2.9 for Q1 2026, down 186.03% sequentially from 1.01 in Q4 2025.

BridgeBio Oncology Therapeutics (BBOT) Interest Coverage Ratio (2024 - 2026) Analysis & Trends

BridgeBio Oncology Therapeutics has reported Interest Coverage Ratio for 3 years, with the latest figure at 2.9 in Q1 2026.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 2.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.79 (changed N/A YoY) and the FY2025 annual result came in at 1.67, up 6.55% from the prior year.
Interest Coverage Ratio slipped to 2.9 in Q1 2026 per BBOT's latest filing, from 1.01 in the prior quarter.
Over five years, Interest Coverage Ratio peaked at 0.48 in Q4 2024 and troughed at 2.9 in Q1 2026.
A 3-year average of 1.44 and a median of 1.19 in 2025 frame the typical range for Interest Coverage Ratio.
The widest YoY moves for Interest Coverage Ratio: up 109.57% in 2025, down 109.57% in 2025.
Over 3 years, Interest Coverage Ratio stood at 0.48 in 2024, then tumbled by 109.57% to 1.01 in 2025, then plunged by 186.03% to 2.9 in 2026.
According to Business Quant data, Interest Coverage Ratio over the past three periods registered 2.9, 1.01, and 1.37 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	2.84
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	24.64
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-0.19
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	8.18
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-0.01
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.61
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	2.82
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-0.08
10	BridgeBio Oncology Therapeutics	726.38 Mn	500.67 Mn	-	-5.67

Download Data